TEVA Director Ronit Satchi-Fainaro Sells 415 Shares

What Happened
Ronit Satchi-Fainaro, a director of Teva Pharmaceutical Industries Ltd (TEVA), sold 415 ordinary shares in an open-market transaction on August 21, 2026. The shares were sold at $37.25 per share for total proceeds of $15,459. This was a sale (not a purchase) and therefore does not represent an insider accumulation signal.

Key Details

• Transaction date: 2026-08-21
• Transaction type/code: Open-market sale (Form 4 code S)
• Price per share: $37.25
• Shares sold: 415
• Total proceeds: $15,459
• Shares owned after transaction: Not specified in the filing
• Footnote: The ordinary shares may be represented by American Depositary Shares (ADS), each currently representing one ordinary share (Footnote F1).
• Filing date: Form 4 filed 2026-08-25 — appears timely (within required reporting window).

Context
Insider sales can be routine (liquidity, portfolio rebalancing, tax needs) and do not by themselves indicate negative company fundamentals; purchases typically carry more weight for signaling insider confidence. The filing contains no indication of option exercises, gifts, a 10b5-1 plan, or other derivative transactions.